Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hironori, Tsujimoto"'
Autor:
Naoyuki Uehata, Keita Kouzu, Hironori Tsujimoto, Hidekazu Sugasawa, Kotaro Wakamatsu, Yoji Kishi, Hideki Ueno
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background The prognosis of recurrent and unresectable gastric cancer remains poor despite the development of multidisciplinary treatments. Ramucirumab (RAM) has been proven effective against unresectable or recurrent gastric cancer. However
Externí odkaz:
https://doaj.org/article/711f3df557364a6f90227584b91e1ada
Autor:
Hiromi Nagata, Hironori Tsujimoto, Yoshihisa Yaguchi, Keita Kouzu, Yujiro Itazaki, Yusuke Ishibashi, Satoshi Tsuchiya, Takao Sugihara, Nozomi Ito, Manabu Harada, Shinsuke Nomura, Yoshitaka Utsumi, Hideyuki Shimazaki, Yoji Kishi, Hideki Ueno
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-6 (2020)
Abstract Background Trastuzumab (T-mab)-based chemotherapy is a standard regimen for human epithelial growth factor 2 (HER2)-positive gastric cancer. However, some patients have demonstrated a change in HER2 status after T-mab-based treatment of brea
Externí odkaz:
https://doaj.org/article/c8d2d582a64a48efbab4f32db8699ac4
Autor:
Manabu Harada, Hironori Tsujimoto, Takashi Ichikura, Hiromi Nagata, Nozomi Ito, Shinsuke Nomura, Hiroyuki Horiguchi, Yoshihisa Yaguchi, Yoji Kishi, Hideki Ueno
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Alpha-fetoprotein-producing gastric cancer (AFP-GC) is a relatively rare disease, with a dismal prognosis. Case presentation We report the case of a patient with long-term survival after surgery for the recurrence of AFP-GC. A 71-
Externí odkaz:
https://doaj.org/article/dbc82c78e03a4a13bb0b536cfa733a5a
Autor:
Hidekazu Sugasawa, Kotaro Wakamatsu, Hideki Ueno, Hironori Tsujimoto, Naoyuki Uehata, Keita Kouzu, Yoji Kishi
Publikováno v:
Surgical Case Reports
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Background The prognosis of recurrent and unresectable gastric cancer remains poor despite the development of multidisciplinary treatments. Ramucirumab (RAM) has been proven effective against unresectable or recurrent gastric cancer. However, its adm
Autor:
Yoji Kishi, Hironori Tsujimoto, Takashi Ichikura, Shinsuke Nomura, Hiroyuki Horiguchi, Nozomi Ito, Yoshihisa Yaguchi, Manabu Harada, Hideki Ueno, Hiromi Nagata
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Surgical Case Reports
Surgical Case Reports
Background Alpha-fetoprotein-producing gastric cancer (AFP-GC) is a relatively rare disease, with a dismal prognosis. Case presentation We report the case of a patient with long-term survival after surgery for the recurrence of AFP-GC. A 71-year-old
Autor:
Nozomi Ito, Yoshihisa Yaguchi, Yusuke Ishibashi, Yoshitaka Utsumi, Keita Kouzu, Hideyuki Shimazaki, Satoshi Tsuchiya, Hiromi Nagata, Shinsuke Nomura, Takao Sugihara, Manabu Harada, Yujiro Itazaki, Hironori Tsujimoto, Yoji Kishi, Hideki Ueno
Publikováno v:
Surgical Case Reports
Surgical Case Reports, Vol 6, Iss 1, Pp 1-6 (2020)
Surgical Case Reports, Vol 6, Iss 1, Pp 1-6 (2020)
Background Trastuzumab (T-mab)-based chemotherapy is a standard regimen for human epithelial growth factor 2 (HER2)-positive gastric cancer. However, some patients have demonstrated a change in HER2 status after T-mab-based treatment of breast cancer
Autor:
Junji Yamamoto, Hironori Tsujimoto, Akifumi Kimura, Suefumi Aosasa, Kazuo Hase, Takuji Noro, Makoto Nishikawa
Publikováno v:
Surgical Case Reports
The right gastroepiploic artery (RGEA) has been used in coronary artery bypass grafting (CABG) as an alternative graft. In particular abdominal surgeries, surgery is required to rescue the graft flow into the coronary artery. A 77-year-old male with